Section I
221 – 230 of 5061
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation : Final overall survival results from the OPINION trial
- Contribution to journal › Article
-
Mark
Twenty Years of the Paediatric Radiation Oncology Society
- Contribution to journal › Article
-
Mark
Impact of the risk-adapted Nordic anal cancer group consensus guidelines on the contouring of the elective clinical target volume in anal cancer
- Contribution to journal › Article
-
Mark
Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies
- Contribution to journal › Article
-
Mark
Response-Letter to the Editor : Consensus Statements on End-Of-Life Care in ICU
- Contribution to journal › Article
-
Mark
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer
- Contribution to journal › Article
-
Mark
Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol
- Contribution to journal › Article
-
Mark
Reporting Bone Cytopathology-A Proposal Based on a Single Tertiary Centre Experience
- Contribution to journal › Article
-
Mark
Delade åsikter om dödshjälp bland palliativ vårdpersonal
(2025) In Läkartidningen
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
- Contribution to journal › Article
